These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 15792755)
61. Threshold and retreatment parameters of NPe6 photodynamic therapy in retinal and choroidal vessels. Peyman GA; Kazi AA; Moshfeghi D; Unal M; Khoobehi B; Yoneya S; Mori K; Rivera I Ophthalmic Surg Lasers; 2000; 31(4):323-7. PubMed ID: 10928670 [TBL] [Abstract][Full Text] [Related]
62. A safety study of a novel photosensitizer, sinoporphyrin sodium, for photodynamic therapy in Beagle dogs. Lin N; Li C; Wang Z; Zhang J; Ye X; Gao W; Wang A; Jin H; Wei J Photochem Photobiol Sci; 2015 Apr; 14(4):815-32. PubMed ID: 25671327 [TBL] [Abstract][Full Text] [Related]
63. Pretreatment photosensitizer dosimetry reduces variation in tumor response. Zhou X; Pogue BW; Chen B; Demidenko E; Joshi R; Hoopes J; Hasan T Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1211-20. PubMed ID: 16504761 [TBL] [Abstract][Full Text] [Related]
64. Fluence plays a critical role on the subsequent distribution of chemotherapy and tumor growth delay in murine mesothelioma xenografts pre-treated by photodynamic therapy. Wang Y; Wang X; Le Bitoux MA; Wagnieres G; Vandenbergh H; Gonzalez M; Ris HB; Perentes JY; Krueger T Lasers Surg Med; 2015 Apr; 47(4):323-30. PubMed ID: 25639847 [TBL] [Abstract][Full Text] [Related]
65. [Clinical photodynamic diagnosis and therapy efficiency in oropharyngeal cancer]. Konomi U; Yoshida T; Ito H; Shimizu A; Shimizu S; Okamoto I; Suzuki M Nihon Jibiinkoka Gakkai Kaiho; 2009 May; 112(5):429-33. PubMed ID: 19517799 [TBL] [Abstract][Full Text] [Related]
66. Photodynamic therapy using talaporfin sodium induces heme oxygenase-1 expression in rat malignant meningioma KMY-J cells. Takahashi T; Suzuki S; Misawa S; Akimoto J; Shinoda Y; Fujiwara Y J Toxicol Sci; 2018; 43(5):353-358. PubMed ID: 29743446 [TBL] [Abstract][Full Text] [Related]
67. Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response. Ferrario A; Rucker N; Wong S; Luna M; Gomer CJ Cancer Res; 2007 May; 67(10):4989-95. PubMed ID: 17510430 [TBL] [Abstract][Full Text] [Related]
68. Photodynamic therapy as an effective therapeutic approach in MAME models of inflammatory breast cancer. Aggarwal N; Santiago AM; Kessel D; Sloane BF Breast Cancer Res Treat; 2015 Nov; 154(2):251-62. PubMed ID: 26502410 [TBL] [Abstract][Full Text] [Related]
69. Photodynamic efficacy of topical application of chlorin e6--polyvinyl pyrrolidone complex in tumor-bearing rats. Istoin YP; Laptsevich TP; Bizyuk SA; Alexandrova EN Exp Oncol; 2006 Dec; 28(4):299-302. PubMed ID: 17285114 [TBL] [Abstract][Full Text] [Related]
71. In vivo studies on the utilization of mono-L-aspartyl chlorin (NPe6) for photodynamic therapy. Nelson JS; Roberts WG; Berns MW Cancer Res; 1987 Sep; 47(17):4681-5. PubMed ID: 2957047 [TBL] [Abstract][Full Text] [Related]
73. Tailor-made approach to photodynamic therapy in the treatment of cancer based on Bcl-2 photodamage. Usuda J; Hirata T; Ichinose S; Ishizumi T; Inoue T; Ohtani K; Maehara S; Yamada M; Tsutsui H; Okunaka T; Kato H; Ikeda N Int J Oncol; 2008 Oct; 33(4):689-96. PubMed ID: 18813781 [TBL] [Abstract][Full Text] [Related]
74. Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6). Mori K; Yoneya S; Ohta M; Sano A; Anzai K; Peyman GA; Moshfeghi DM Ophthalmology; 1999 Jul; 106(7):1384-91. PubMed ID: 10406627 [TBL] [Abstract][Full Text] [Related]
75. Photosensitizing properties of mono-L-aspartyl chlorin e6 (NPe6): a candidate sensitizer for the photodynamic therapy of tumors. Spikes JD; Bommer JC J Photochem Photobiol B; 1993 Feb; 17(2):135-43. PubMed ID: 8459317 [TBL] [Abstract][Full Text] [Related]
76. Uptake and retention of the photosensitizer mono-L-asparthyl chlorine e6 in experimental malignant glioma. Matsumura H; Akimoto J; Haraoka J; Aizawa K Lasers Med Sci; 2008 Jul; 23(3):237-45. PubMed ID: 17703335 [TBL] [Abstract][Full Text] [Related]
77. Bid is required in NPe6-PDT-induced apoptosis. Wan Q; Liu L; Xing D; Chen Q Photochem Photobiol; 2008; 84(1):250-7. PubMed ID: 18173728 [TBL] [Abstract][Full Text] [Related]
78. Blood flow dynamics after photodynamic therapy with verteporfin in the RIF-1 tumor. Chen B; Pogue BW; Goodwin IA; O'Hara JA; Wilmot CM; Hutchins JE; Hoopes PJ; Hasan T Radiat Res; 2003 Oct; 160(4):452-9. PubMed ID: 12968929 [TBL] [Abstract][Full Text] [Related]
79. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo. Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168 [TBL] [Abstract][Full Text] [Related]
80. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma. Bhuvaneswari R; Gan YY; Yee KK; Soo KC; Olivo M Int J Mol Med; 2007 Oct; 20(4):421-8. PubMed ID: 17786271 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]